A comprehensive new study spanning 20 years and 57 vaccines finds vaccines are "remarkably safe" — safer, in fact, than "almost any other modern medical intervention," lead author Dr. Daniel Shepshelovich told Business Insider.

For the study, he and other researchers at Tel Aviv Sourasky Medical Center looked at the labels, including safety-related changes, of 57 vaccines that became FDA-approved between the beginning of 1996 and end of 2015.

Taking a Shot at HPV Prevention!

Young fans who attend the Falmouth High girls’ basketball game on Jan. 31 and the Mashpee High boys’ basketball game on Feb. 14 will have the opportunity to spin a prize wheel and participate in a halftime basketball free-throw contest.

At the 3^rd Annual “Take the Shot Night,” they will also, along with their parents/guardians, learn about a different shot that will protect them from the HPV virus and HPV-related cancers.

A new meta-analysis published in The Lancet in June shows the HPV vaccine is very effective and is expected to lower the rate of cervical and other related cancers.

The researchers reviewed data from 60 million young men and women in 14 high-income nations, with up to 8 years of post-vaccination follow-up. Continue to the Cape Cod Health News Article.

‘Is Gardasil 9 right for me?” my patient asked during a recent office visit.

She is 45, recently divorced from her husband of 20 years and crafting her online dating profile. She’s also wondering whether she is a candidate for the vaccine that protects against nine strains of the human papilloma virus (HPV) — a virus that causes most cervical, oral and anal cancer.

Jason Mendelsohn was pondering a question during a financial exam in 2014 when his fingers grazed his neck, making him notice a bump he hadn’t felt before.

He consulted his father, a doctor, who told him they’d need to call an ear, nose and throat physician. This led to a doctor’s consultation, which eventually led to a diagnosis. At 44, he was told he had HPV-related throat cancer.

CDC today recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses to protect against cancers caused by human papillomavirus (HPV) infections. Teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.

A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said Monday.

Merck announced that the Food and Drug Administration (FDA) has expanded the age indication for Gardasil 9 (human papillomavirus 9-valent vaccine [recombinant]) in males. It now includes use in males aged 16–26 for the prevention of anal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 59; precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; and genital warts caused by HPV types 6 and 11.

More adolescents received the HPV vaccine when the vaccine was discussed in the context of other vaccines, and when the providers said they expected that the vaccine would be administered at the visit, results from a multisite study suggest.

Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness.

The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls.

"When administered to adolescents, the HPV4 vaccine demonstrated durability in clinically effective protection and sustained antibody titers over eight years," concluded the researchers.

A new study from the Karolinska Institutet in Sweden found no association between the human papillomavirus (HPV) vaccine and short- or long-term health concerns.